Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: More on trial

First, like others, I thank you sincerely for your reporting. It's much appreciated.

However, as I wrote to kiddtrader, I believe the Apple deal was for many millions of dollars, but TPL unilaterally allocated only a small portion of it to the MMP, and much larger disproportionate amounts to their other portfolios. To illucidate this to a jury in court in THIS trial, is not helpful to our position, IMO, as it puts our side, and especially TPL in a bad light and brings our internal dirty laundry to the light of day, in a forum where that's not helpful.

That being said, was their any further disclosure about the structture of that multi-portfolio Apple license? Were the overall dollar figures revealed, or did they stick to just the portion allocated as the MMP fee, and keep the rest of the sordid tale in the dark? Like you say, hopefully that issue is prevented now from ever recurring, but I hope something can be presented to the jury that explains not only the Apple license as being discounted beacuse of "survival mode" licensing, but also explains that the deal was for much more, and SHOULD HAVE allocated much more to the MMP fee, without creating more damage by going into the subject.

Share
New Message
Please login to post a reply